QUINCE THERAPEUTICS INC (QNCX) Stock Analyst Ratings
NASDAQ:QNCX • US22053A1079
0.1257 USD
-0.01 (-9.24%)
At close: Feb 27, 2026
0.1201 USD
-0.01 (-4.46%)
After Hours: 2/27/2026, 8:00:02 PM
ChartMill assigns a Buy % Consensus number of 53% to QNCX. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 6.12. This target is 4768.74% above the current price.
- QNCX was analyzed by 11 analysts. The buy percentage consensus is at 53. So analysts seem to be rather neutral about QNCX.
- In the last month the buy percentage fell by 30 points. So the trust of analysts is decreasing.
- QNCX was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-30 | Citizens | Downgrade | Market Outperform -> Market Perform |
| 2026-01-30 | D. Boral Capital | Downgrade | Buy -> Hold |
| 2026-01-29 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-12-15 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-11-13 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-09-26 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-15 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-12 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-08-05 | JMP Securities | Initiate | Market Outperform |
| 2025-07-17 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-06-13 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-06-04 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-03-25 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-03-24 | Oppenheimer | Initiate | Outperform |
| 2025-02-05 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-01-02 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-12-18 | Brookline Capital | Initiate | Buy |
| 2024-11-14 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-11-12 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-11-07 | Maxim Group | Initiate | Buy |
| 2024-10-29 | Rodman & Renshaw | Initiate | Buy |
| 2024-10-22 | EF Hutton | Initiate | Buy |
QUINCE THERAPEUTICS INC / QNCX FAQ
Can you provide the average price target for QUINCE THERAPEUTICS INC stock?
11 analysts have analysed QNCX and the average price target is 6.12 USD. This implies a price increase of 4768.74% is expected in the next year compared to the current price of 0.1257.
Can you provide the consensus rating for QUINCE THERAPEUTICS INC stock?
The consensus rating for QUINCE THERAPEUTICS INC (QNCX) is 52.7273 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
How many analysts have analysed QUINCE THERAPEUTICS INC (QNCX)?
The number of analysts covering QUINCE THERAPEUTICS INC (QNCX) is 11.